News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Private Equity Firms Mull $10 Billion Merger Of Older GlaxoSmithKline (GSK), Sanofi (France) (SAN.PA) Brands



8/4/2014 11:05:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain's GlaxoSmithKline (GSK.L) and France's Sanofi (SASY.PA), the Financial Times reported on Sunday, citing sources.

U.S.-based KKR (KKR.N) and Warburg Pincus WP.UL were among the firms considering making bids for assets owned by GSK and Sanofi, the newspaper quoted several people familiar with the matter as saying. (on.ft.com/1oo8n5j)

GSK Chief Executive Andrew Witty in April said the drugmaker was reviewing its portfolio of mature products and wanted to dispose of off-patent drugs marketed in North America and Western Europe.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES